Skip to main content

New hopes for personalised cancer treatment

In the news today:
A new multi million pound laboratory in west London is to be the first institute in Europe to sequence patients genomes in a matter of days for personalised cancer treatment.
'Cancer' headline on newspaper (getty)
The Tumour Profiling Unit run by The Institute of Cancer Research (ICR) in Chelsea will use state-of-the-art techniques such as genome sequencing, epigenetics and imaging to identify a patient’s cancer at the start of diagnosis then track the cancer as it progresses, mutates and develops resistance to drugs throughout a patient’s course of treatment, writes our science reporter Asha Tanna.
In the next five to ten years tumour molecular profiling for cancer therapies should be "absolute routine practice" for every patient.
The comment from ICR’s chief executive Alan Ashworth, professor of molecular biology went on: “Every cancer is different to every patient. But they are built from the same principles that they have to do certain things to clarify them as a cancer.
“Our understanding of the biology of cancer is advancing and genome sequencing has revolutionised the way we do science. Through personalised therapy not only can we tailor it to the individual, but the treatment of that patient can be adjusted as the genetic profile of their tumour changes.”
It took a decade of work and around £2 bn to produce the first draft of the human genome, or genetic code, in 2000. Today a person's genome can be sequenced in a day or two for as little as £3,000.
Let's design the trials for success rather than failure.Alan Ashworth, professor of molecular biology
The team also aims to develop “liquid biopsies” that search for free-floating cancer DNA in blood samples which hope to identify cancer sub-types.
Dr Nick Turner clinical researcher at the ICR said: “Repeated biopsy is difficult for patients. Cancer releases cells into the circulation. By analysing the cancer DNA in blood it is similar to carrying out a biopsy but it is done in real time because it is from a blood sample.
“Resistance in cancer is inevitable. Which patients respond to drugs and which don’t is difficult to predict. In some cases it may be suitable to give patients “drug holidays”, where they are taken off drugs for a while and then perhaps put back on different drugs. Bu using combined therapies we can monitor drug resistance before deciding what treatment is suitable.”
The attitude that one therapy fits all is changing rapidly in oncology. Professor Ashworth added: “We need to identify subgroups that have a proportionately larger benefit, say 25 per cent, which means that you intrinsically need many fewer patients."
"Let's design the trials for success rather than failure. Basically the way we're developing drugs for cancer is now failing big time. Certainly, the idea of developing old-fashioned chemotherapy is going out the window."

Labels:

Comments

Post a Comment

Popular posts from this blog

Kate Jackson Breast Cancer a flash back

THE MOST MOMENTOUS CHANGE IN Kate Jackson's life began early one morning in January 1987, during her fourth season on the hit TV series Scarecrow and Mrs. King. After a phone call informed her that the show's taping was canceled because costar Bruce Boxleitner had the flu, Jackson went back to sleep. When she woke several hours later, "It was out of the blue, but perfectly clear," she recalls. "I sat up in bed and literally said, 'You have to have a mammogram.' " She did, and two days later a biopsy confirmed her vague fears: A minute growth found in her left breast was determined to be malignant. "I was forced to face, squared up, my own mortality," says Jackson. "I had to decide whether I wanted to live or to die. And if you choose life, as I did, it's never the same." For three TV seasons 16 years ago, she was famous as Sabrina Duncan, a girl-next-door gone glamorous and the character critics dubbed the brainiest o
Post a Comment
Read more

The four stages of breast development

In Stage 1 shows the flat breasts of childhood. By Stage 2, breast buds are formed as milk ducts and fat tissue develop. In Stage 3, the breast become round and full, and the areola darkens. Stage 4 shows fully mature breasts. (Illustration by GGS Information Services.) period begins. Usually these signs are accompanied by the appearance of pubic hair and hair under the arms. Once ovulation and  menstruation  begin, the maturing of the breasts begins with the formation of secretory glands at the end of the milk ducts. The breasts and duct system continue to grow and mature with the development of many glands and lobules. The rate at which breasts grow varies significantly and is different for each young woman. Breast development occurs in five stages: Stage One: In preadolescence, the breasts are flat and only the tip of the nipple is raised. Stage Two: Buds appear, breast and nipple are raised, fat tissue begins to form and the areola (dark area of skin that surrounds
1 comment
Read more

"Hard nipples" - areola or nipple skin

Someone once wrote"... when i get really cold, or get goosebumbs all over my body, the whole things really scrunch up, like, my entire areola scrunches itself up into a wrinkled little mound. it looks really weird and ugly, and i haven't ever seen other people's breasts do it. what is wrong with my areola/nipples??" The answer: Well nothing is wrong. This is what my areola does too. It's a normal reaction to the coldness or to irritation / stimulation. The little muscles in the areola do a similar goosebump thing as your other skin can do. People often call this phenomenon "hard nipples". Also note that skin on areola has less feeling or sensation to it than other areas of your body. If the areola was very sensitive, then breastfeeding would probably be quite uncomfortable because the baby pulls and tugs it! The nipples are sensitive but the sensitivity changes with hormonal changes, such as occur at mestrual cycle or pregnancy. Also this v
8 comments
Read more